Epigenetics, exposome and development of the intestinal microbiota in the neonate

Authors

  • Paola Sánchez Benitez Faculty of Chemical Sciences Autonomous University of Puebla. Av. San Claudio and 18 Sur, Building 105-H, City University C. P. 72570 Puebla, Mexico.
  • Rocío Pérez y Terrón Microbiology and Molecular Biology Laboratory, Biological Sciences Faculty, Autonomous University of Puebla, Building 112-A, City University C. P. 72570 Puebla, Mexico.

DOI:

https://doi.org/10.30574/gscbps.2020.13.2.0367

Keywords:

Epigenetics, Exposome, Microbiota, Neonate

Abstract

The intestinal microbiota is currently known as a "metabolic organ" that significantly influences the health of the host from the first years of life, being a crucial factor for optimal development of immunity and regulation of different physiological processes such as digestion, absorption, metabolism and synthesis of nutrients. This work aims to show the relationship between epigenetics, the exposome and the development of the intestinal microbiota in the newborn according to the route of birth. A documentary review of the literature of the last 5 years was carried out and it was found that the majority of non-communicable diseases are due to epigenetic modifications that can occur in the prenatal stages, together with environmental factors that also contribute to these epigenetic changes, term known as an exposome. In this sense, the greatest exposure of microorganisms for the development of intestinal colonization is at the time of birth, being Bifidobacterium one of the most important genera that contribute to immune function, found to a lesser extent in newborns born by abdominal route (cesarean section ), this type has been associated with dysbiosis of the intestinal microbiota, generating consequences in the development of diseases such as obesity, diabetes, asthma, food allergy and autism spectrum disorder. Allowing to conclude that both epigenetics and the exposome and the intestinal microbiota are simultaneously related from the early stages of life and can be the cause of various non-communicable diseases.

Metrics

Metrics Loading ...

References

Keklikián RI, Coronel AV. Microbiome and epigenetics in perinatology. 1000 days that can change destinies. Clínicas Perinatológicas Argentinas. ASAPER. 2018; 140-178.

Cuadros CA, Ignorosa KR, Zárate FE, Toro E, Cervantes R, Montijo E, Cadena J, Serrano A, Ramírez JA. The exposome influence in the first 1,000 days old and gastrointestinal Health. Acta Pediatr Mex. 2018; 39(3): 265-277.

Harris PR. What do we know about the importance of the intestinal microbiota throughout life? Gastroenterol. Latinoam. 2019; 30(1): 13- 17.

Pacheco Y, Bello Z, Góngora K. Human microbiome, implications in the health-disease process. Rev. electron. Zoilo. 2018; 44(1): 1-9.

Michel ARJ, Izeta GAC, Torres AG, Michel ACMI. The microbiota and the human gut microbiome. (Between the keys to the kingdom and a new Pandora's box).Rev Sanid Milit Mex. 2017; 71(5): 443-448.

Tinahones F. The importance of the microbiota in obesity. Rev Esp Endocrinol Pediatr. 2017; 8(1): 16-20.

Rutayisire E, Huang K, Liu Y, Tao F. The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants' life: a systematic review. BMC Gastroenterol.2016; 16(86): 1-12.

Torrachi A, Arcos M, Ochoa S, Mora M, Radax J, Palacios M, Salgado C. Bibliographic Review: The Human Microbiome. Rev Med HJCA. 2017; 9(3): 275-279.

Francavilla R, Cristofori F, Tripaldi ME, Indrio F. Intervention for Dysbiosis in Children Born by C-Section. Ann Nutr Metab. 2018; 73 (3): 33–39.

Sierra A, López O, Boj Ji, Milagro FI, Martínez A. Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications. Advances in Nutrition. 2019; 10(1): 17–30.

Zamudio VP, Ramírez JA, Toro EM, Cervantes R, Zárate F, Montijo E, Cervantes R, Zarate F, Montijo E, Cadena JF, Cázares JM. Importance of the gastrointestinal microbiota in pediatrics. Acta Pediatr Mex. 2017; 38(1): 49-62.

Mancilla J. The birth path as a disease programmer. Rev Mex Pediatr. 2015; 82(4): 121–123.

Butel M, Waligora A, Wydau S. The developing gut microbiota and its consequences for health. J Dev Orig Health Dis. 2018; 9(6): 590-597.

Zhuang L, Chen H, Zhang S, Zhuang J, Li Q, Feng Z. Intestinal Microbiota in Early Life and Its Implications on Childhood Health. Genomics, proteomics & bioinformatics. 2019; 17(1): 13–25.

Sadler, Michelle. The Effects of Cesarean Section on Child Health: An Urgent Matter. Rev Chil Pediatr. 2018; 89(4): 561-562.

OCDE Health Statistics. Why so much variation in caesarean section rates in OECD countries? 2020 [cited 2020 August 05]. Available from: http://www.oecd.org/els/health-systems/graph-of-the-month.htm

Alonso E. M. G. Evolution of birth by cesarean section: The case of Mexico. DILEMATA 2015; (18): 27-43.

Sepúlveda DL, Galván M, Soto GA, Méndez, DH. Factors associated with successful delivery of women with a history of cesarean section. Ginecol Obstet Mex. 2015; 83(12): 743-749.

Bernal C, Nahín C. Cesarean section: current situation and associated factors in Mexico. Salud Quintana Roo. 2018; 11(40): 28-33.

Serrano CA, León MA, Harris PR. Development of the gastrointestinal microbiota in infants and its role in health and disease. ARS MEDICA Revista De Ciencias Médicas. 2016; 41(1): 35-43.

Calderón X, Guerrero A. Generalities in intestinal microbiota. Acta Científica de la Sociedad Venezolana de Bioanalistas Especialistas. 2019; 2(1): 27-34.

Abdellatif AM, Sarvetnick NE. Current understanding of the role of gut dysbiosis in type 1 diabetes. Journal of Diabetes. 2019; 11 (8): 632-644.

Uberos J. Perinatal microbiota: Review of its importance in newborn health. Arch Argent Pediatr. 2020; 118(3): 265-270.

Mena VR, Fernández BDLP. Relationship between intestinal microbiota, epigenetics and exposome in maternal and child health. Rev Cubana de Pediatr. 2019; 91(2): 1-13.

Luna EJ, Castro M, León D. Epigenetics in the course of life: a challenge in the continuous training of health personnel. Rev Med Electrón. 2020; 42(1): 1669-1673.

Ortega F, Chavira E, Piña G, Bárbara P. Adverse environmental factors during pregnancy: fetal epigenetic adjustments and their consequences on the phenotype. Mens. Bioquim. 2017; 41: 29-36.

Castro JA, Krause BJ, Uauy R, Casanello P. Epigenetics in allergic diseases and asthma. Rev Chil de Pediatr. 2016; 87(2): 88-95.

Berrocal JC, Gamez GD, Martínez LB, Redondo NG, Diazgranados IL, Acosta JI. Epigenetics and chronic non-communicable diseases. Archivos de medicina. 2019; 15(4): 1-8.

Santos S, Maitre L, Warembourg C, Agier L, Richiardi L, Basagaña X, Vrijheid M. Applying the exposome concept in birth cohort research: a review of statistical approaches. Eur J Epidemiol. 2020; 35(3): 193-204.

Vicente MT, Ramírez MV, Capdevila LM, Terradillos MJ, López AA, Jiménez E, Reinoso L. Exposoma: a new concept in Occupational Health and Public Health. Rev Asoc Esp Espec Med Trab. 2016; 25(3): 176-183.

DeVries A, Vercelli D. The neonatal methylome as a gatekeeper in the trajectory to childhood asthma. Epigenomics. 2017; 9(4): 585–593.

Maghbooli Z, Hossein A, Adabi E, Asadollah E, Sadeghi M, Mohammad S, Zakeri L, Malek A, Radmehr M, Faghihi F, Aghaei A, Omidifar A, Aghababei Y, Behzadi H. Air pollution during pregnancy and placental adaptation in the levels of global DNA methylation. PLoS One. 2018; 13(7): 1-14.

Ihekweazu FD, Versalovic J. Development of the Pediatric Gut Microbiome: Impact on Health and Disease. A.m. J. Med. Sci. 2018; 356(5): 413–423.

Milani C, Durant S, Bottacini F, Casey E, Turroni F, Mahony J, Belzer C, Delgado S, Arboleya S, Mancabelli L, Lugli GA, Rodríguez JM, Bode L, de Vos W, Gueimonde M, Margolles A, van Sinderen D, Ventura M. The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota. Microbiology and Molecular Biology Reviews: MMBR. 2017; 81(4): 1-67.

Pérez ME, Arrieta MC, Ramer AE, Walter J. A critical assessment of the “sterile womb” and “in utero colonization” hypotheses: implications for research on the pioneer infant microbiome. Microbiome. 2017; 5(48): 1-19.

Moreno JM, Collado MC, Larqué Elvira, Leis MR, Sáenz M, Moreno LA. The first 1000 days: an opportunity to reduce the burden of noncommunicable diseases. Nutr Hosp. 2019; 36(1): 218-232.

Arboleya S, Suárez M, Fernández N, Mantecón L, Solís G, Gueimonde M, Reyes CG. C-section and the Neonatal Gut Microbiome Acquisition: Consequences for Future Health. Ann Nutr Metab. 2018; 73(3): 17-23.

Carrasco IR, Lozano JC, Castañeda PC. Cesarean section as a conditioning factor for constipation, dermatitis and allergies in children of two units of the Mexican Institute of Social Security. Alergia, Asma e Inmunología Pediátricas. 2015; 24(1): 5-11.

Navia LA, Ignorosa KR, Zárate FE, Bustamante R, Monjaraz EM, León JF, Mayans J. Gastrointestinal microbiota and its relationship with allergy. Acta Pediatr Mex. 2020; 41 (3): 135-147.

Shao Y, Forster SC, Tsaliki E, Vervier K, Strang A, Simpson N, Kumar N, Stares M, Rodger A, Brocklehurst P, Field N, Lawley T. Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature. 2019; 574(7776): 117-121.

Dalby MJ, Hall LJ. Recent advances in understanding the neonatal microbiome. F1000 Research. Faculty Rev. 2020; 9(422): 1-8.

Jagodzinski A, Zielinska E, Laczmanski L, Hirnle L. The early years of life. Are they influenced by our microbiome? Ginekologia polska. 2019; 90(4): 228–232.

Mesa MD, Loureiro B, Iglesia I, Fernández S, Llurba E, García O, Solana MJ, Cabero MJ, Sainz T, Martínez L, Escuder D, Parra A, Sánchez M, Rodríguez G, Gómez D, Pérez M, Andreu V, Clotet J, Sailer S, Iglesias I, Cabañas F. The Evolving Microbiome from Pregnancy to Early Infancy: A Comprehensive. Review Nutrients. 2020; 12(133): 2-21.

Tribe RM, Taylor PD, Kelly NM, Rees D, Sandall J, Kennedy HP. Parturition and the perinatal period:can mode of delivery impact on the future health of the neonate? J Physiol. 2018; 596(23): 5709-5722.

León LM, Gómez MF, Jiménez YC, Yenesis C, González MC, Moreno EA, Suárez E, Hernández AE, Mandujano JI, Payan T, Contreras MR, Hernández M, Guzmán LA y Hernández RA. Profile of the healthy term newborn in a private institution in Western Mexico. Rev. Med MD. 2016; 7(4): 275-279.

Zhang T, Sidorchuk A, Sevilla L, Vilaplana A, Chang Z, Larsson H, Mataix D, Fernández L. Association of Cesarean Delivery With Risk of Neurodevelopmental and Psychiatric Disorders in the Offspring: A Systematic Review and Meta-analysis. JAMA network open. 2019; 2(8): 1-19.

Peroni DG, Nuzzi G, Trambusti I, Di Cicco ME, Comberiati P. Microbiome Composition and Its Impact on the Development of Allergic Diseases. Frontiers in immunology. 2020; 11(700): 1-8.

Montealegre SMF, Muñoz MFM, Vargas JFV. Cesarean delivery as a risk factor for the development of asthma in childhood. Rev Med Sinergia. 2019; 4(9): 3-3.

Nance CL, Deniskin R, Diaz VC, Paul M, Anvari S, Anagnostou A. The Role of the Microbiome in Food Allergy: A Review. Children (Basel). 2020; 7(50): 1-18.

Lugo NT, Martínez MH. Epigenetic mechanisms and the Notch signaling pathway at the origin of different congenital defects. Medicentro. 2018; 22(3): 197-207.

Downloads

Published

2020-11-30

How to Cite

Paola Sánchez Benitez, & Rocío Pérez y Terrón. (2020). Epigenetics, exposome and development of the intestinal microbiota in the neonate. GSC Biological and Pharmaceutical Sciences, 13(2), 199–210. https://doi.org/10.30574/gscbps.2020.13.2.0367

Issue

Section

Original Article